ALL NEWS

On 15 June the GI Cancer Institute held an instalment of the Living Room Series in Sydney. Two... Read More

Trial update: NABNEC The NABNEC trial is almost halfway to its accrual target, with 31 participants at the end... Read More

Dear Members, At the beginning of this month I attended the ASCO Annual Meeting in Chicago. At the meeting... Read More

Highlighting Stomach Cancer with the Silly Hat for Matt Challenge In 2018 Trine Simpson and her friends, set up... Read More

This week is Neglected Cancers’ Awareness Week – bringing attention to those rare and less common cancers that... Read More

Trial news: The AGITG currently has thirteen studies open to recruitment and five studies in follow up. The... Read More

The preliminary results of the ALT-GIST clinical trial have been released at the ASCO Annual Meeting. ALT-GIST investigated the... Read More

The preliminary results of the ALT-GIST clinical trial were released at the ASCO Annual Meeting. ALT-GIST was a phase... Read More

Dear Members, Monday 20 May was International Clinical Trials Day. This was an opportunity to reflect on the dedication... Read More

ALT-GIST results to be presented at ASCO The preliminary results of the phase II ALT-GIST study will be presented... Read More

Professor Tim Price, Chair of the GI Cancer Institute Board, has dedicated much of his working career to... Read More